Interaction of drugs for eradication therapy against antibiotic- resistant strains of Helicobacter pylori

Microbiology and Immunology

Volumn 41, Issue 11, 1997, Pages 865-869

  Gotoh, Akira ^a,d   Kawakami, Yoshiyuki ^b   Akamatsu, Taiji ^c   Katsuyama, Tsutomu ^d  

^a Shinshu University   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug interaction; Eradication therapy; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; HELICOBACTER PYLORI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE;

EID: 0031442968     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01942.x     Document Type: Article

References (35)

1. Akamatsu, T., Ota, H., Shimizu, H., Matsuzawa, K., Fujimori, Y., Nakamura, N., Kiyosawa, K., and Katsuyama, T. 1995. Histochemical study of Helicobacter pylori and surface mucous gel layer in various gastric lesions. Acta Histochem. Cytochem. 28: 181-185.
2. Axon, A.T.R. 1991. Helicobacter pylori therapy: effect on peptic ulcer disease. J. Gastroenterol. Hepatol. 6: 131-137.
3. Axon, A.T.R. 1994. The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori - an update. Scand. J. Gastroenterol. 29 (Suppl. 205): 31-37.
4. Bazzoli, F., Zagari, R.M., Fossi, S., Pozzato, P., Alampi, G., Simoni, P., Sottili, S., Roda, A., and Roda, E. 1994. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6: 773-777.
5. Bell, G.D., Powell, K., Burridge, S.M., Pallecaros, A., Jones, P.H., Gant, P.W., Harrison, G., and Trowell, J.E. 1992. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol. Ther. 6: 427-435.
6. Cederbrant, G., Kahlmeter, G., Schalén, C., and Kamme, C. 1994. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxicillin, metronidazole or omeprazole against Helicobacter pylori. J. Antimicrob. Chemother. 34: 1025-1029.
7. Chiba, N., Rao, B.V., Rademaker, J.W., and Hunt, R.H. 1992. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am. J. Gastroenterol. 87: 1716-1727.
8. Cooreman, M.P., Krausgrill, P., and Hengels, K.J. 1993. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob. Agents Chemother. 37: 1506-1509.
9. Coudron, P.E., and Stratton, C.W. 1995. Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob. Agents Chemother. 39: 66-69.
10. Coudron, P.E., and Stratton, C.W. 1995. Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori. Antimicrob. Agents Chemother. 39: 2641-2644.
11. Glupczynski, Y., and Burette, A. 1990. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am. J. Gastroenterol. 85: 1545-1551.
12. Goodwin, C.S. 1988. Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept. Lancet ii: 1467-1469.
13. Goodwin, C.S., Blake, P., and Blincow, E. 1986. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J. Antimicrob. Chemother. 17: 309-314.
14. Gotoh, A., Kawakami, Y., Akahane, T., Akamatsu, T., Shimizu, T., Kiyosawa, K., and Kalsuyama, T. 1997. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiol. Immunol. 41: 7-12.
15. Graham, D.Y., and Börsch, G.M. 1990. The who's and when's of therapy for Helicobacter pylori. Am. J. Gastroenterol. 85: 1552-1555.
16. Graham, D.Y., and Go, M.F. 1993. Helicobacter pylori: current status. Gastroenterology 105: 279-282.
17. Graham, D.Y., Lew, G.M., Klein, P.D., Evans, D.G., Evans, D.J., Saeed, Z.A., and Malaty, H.M. 1992. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern. Med. 116: 705-708.
18. Hindler, J. 1995. Antimicrobial susceptibility testing, 5.16.1-33. In Isenberg, H.D. (ed), Clinical microbiology procedures handbook, Vol. 1, American Society for Microbiology, Washington, D.C.
19. Lambert, T., Mégraud, F., Gerbaud, G., and Courvalin, P. 1986. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob. Agents Chemother. 30: 510-511.
20. Lind, T., van Zanten, S.V., Unge, P., Spiller, R., Bayerdörffer, E., O'Morain, C., Bardhan, K.D., Bradette, M., Chiba, N., Wrangstadh, M., Cederberg, C., and Idström, J.P. 1996. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH1 study. Helicobacter 1: 138-144.
21. Malfertheiner, P. 1993. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand. J. Gastroenterol. 28 (Suppl. 196): 34-37.
22. Marshall, B.J., Goodwin, C.S., Warren, J.R., Murray, R., Blincow, E.D., Blackbourn, S.J., Phillips, M., Waters, T.E., and Sanderson, C.R. 1988. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet ii: 1439-1442.
23. Marshall, B.J., and Warren, J.R. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i: 1311-1314.
24. McNulty, C.A.M., Dent, J.C., Ford, G.A., and Wilkinson, S.P. 1988. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J. Antimicrob. Chemother. 22: 729-738.
25. McNulty, C.A.M., Dent, J., and Wise, R. 1985. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob. Agents Chemother. 28: 837-838.
26. Moayyedi, P., Sahay, P., Tompkins, D.S., and Axon, A.T.R. 1995. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 7: 835-840.
27. Nakao, M., Tada, M., Tsuchimori, K., and Uekata, M. 1995. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 14: 391-399.
28. Pavicic, M.J.A.M.P., Namavar, F., Verboom, T., van Winkelhoff, A.J., and de Graaff, J. 1993. In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations. Antimicrob. Agents Chemother. 37: 1184-1186.
29. Rautelin, H., Seppälä, K., Renkonen, O., Vainio, U., and Kosunen, T.U. 1992. Role of metronidazole resistance in therapy of Helicobacter pylori infection. Antimicrob. Agents Chemother. 36: 163-166.
30. Rauws, E.A., and Tytgat, G.N. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335: 1233-1235.
31. Shimizu, T., Akamatsu, T., Ota, H., and Katsuyama, T. 1996. Immunohistochemical detection of Helicobacter pylori in the surface mucous gel layer and its clinicopathological significance. Helicobacter 1: 197-206.
32. Shimizu, T., Akamatsu, T., Sugiyama, A., Ota, H., and Katsuyama, T. 1996. Helicobacter pylori and the surface mucous gel layer of the human stomach. Helicobacter 1: 207-218.
33. Sung, J.Y., Chung, S.C.S., Ling, T.K.W., Yung, M.Y., Leung, V.K.S., Ng, E.K.W., Li, M.K.K., Cheng, A.F.B., and Li, A.K.C. 1995. Antibacterial treatment of gastric ulcer associated with Helicobacter pylori. New Engl. J. Med. 332: 139-142.
34. Van Caekenberghe, D.L., and Breyssens, J. 1987. In vitro synergistic activity between Bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Antimicrob. Agents Chemother. 31: 1429-1430.
35. Warren, J.R., and Marshall, B.J. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet I: 1273-1275.